Episode Details
Back to Episodes
Insulin Cells WITHOUT Immunosuppressants... Dr. Steve Harr, CEO, Sana Biotechnology
Episode 25032
Published 1 year, 2 months ago
Description
This week on BioTech Nation, Dr. Steve Harr, CEO of Sana Biotechnology, talks about their progress in Type I diabetics, in particular. The New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without immunosuppressant drugs.